查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1880579

貓疫苗市場規模、佔有率、成長及全球產業分析：依類型、應用和地區劃分的洞察與預測（2024-2032）

Feline Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 167 Pages | 商品交期: 請詢問到貨日

價格

貓疫苗市場成長因素

由於寵物主人數量的增加和獸醫護理水準的提高，全球貓疫苗市場持續穩定成長。根據最新的行業分析，在人們對貓健康意識的提高、傳染病流行以及獸醫診所在預防保健中作用的不斷增強等因素的推動下，到2024年，市場規模將達到15.8億美元。受寵物飼養量增長和人畜共患病防治力度加大的推動，預計到2025年，市場規模將進一步增長至16.7億美元。疫苗技術的進步和獸藥生產商投資的增加預計將推動市場規模在2032年達到26.5億美元。

市場推動因素：貓飼養率上升和疾病發生率上升

市場成長的主要推動因素是全球貓數量的顯著成長。隨著越來越多的家庭將貓作為伴侶動物飼養，對疫苗的需求也增加。例如，根據美國寵物用品協會（APPA）的一項調查，到2023-2024年，美國將有約4,900萬戶家庭養貓。高寵物擁有率直接推動了對核心疫苗的需求，例如狂犬病疫苗、貓白血病病毒疫苗 (FeLV) 和貓泛白血球減少症、病毒性呼吸道感染、貓白血病和貓疥瘡疫苗 (FVRCP)。

此外，傳染病的蔓延進一步推動了市場擴張。義大利南部的一項調查發現，在接受檢測的 328 家貓中，73.5% 的貓貓泛白血球減少症病毒檢測呈陽性，凸顯了全球及時接種疫苗的迫切需求。隨著疾病發病率的上升，寵物主人越來越重視透過可靠的疫苗接種計劃來保護他們心愛的貓咪。

市場阻礙因素：發展中地區進入有限

儘管已開發市場有所成長，但新興地區獸醫服務可近性有限仍然是一個重大限制。獸醫數量少、疫苗接種基礎設施薄弱的國家在實施常規貓疫苗接種方面面臨挑戰。例如，肯亞只有 410 名獸醫，這使得大規模疫苗接種計畫難以實施。這最終限制了低收入地區的成長潛力。

市場機會：政府主導的貓疫苗接種計劃

世界各國政府和地方政府正在擴大針對家貓和流浪貓的疫苗接種計劃，從而創造了強勁的市場機會。在印度，納西克市政公司將於 2025 年 7 月啟動流浪貓狂犬病疫苗接種計劃，這反映了以公共衛生為主導的疫苗接種運動的更廣泛趨勢。這些努力正在顯著提高整個地區的疫苗接種率，並支持市場成長，預計到 2032 年市場規模將達到 26.5 億美元。

市場挑戰：寵物主人對疫苗的猶豫

對疫苗的猶豫，主要是由於對疫苗安全性和副作用的擔憂，這仍然是市場擴張的一大挑戰。根據美國獸醫協會 (AVMA) 2024 年報告，許多寵物主人仍不願給寵物接種疫苗，導致疫苗接種率存在差異，並減緩了整體市場接受度。

市場趨勢：疫苗平台的進步

影響產業發展的關鍵趨勢是創新疫苗平台的快速發展，例如重組疫苗和下一代疫苗。默克擴展了 NOBIVAC NXT 平台，其中包括將於 2024 年推出的 NOBIVAC NXT FeLV，凸顯了在更廣泛的保護、更持久的免疫力和更高的安全性方面取得的進展。預計持續的創新將推動2025年至2032年間強勁的需求成長。

區域洞察

北美 - 主要區域市場（2024年：6.7億美元）

北美將佔最大的市場佔有率，達到42.40%，市場規模在2024年將達到6.7億美元。強大的獸醫基礎設施、較高的可支配收入以及龐大的寵物數量支撐著該地區的領先地位。美國憑藉先進的獸醫指南和完善的疫苗分銷網絡，繼續保持其領先地位。

歐洲

由於寵物數量的增長、貓科疾病病例的增加以及政府支持的疫苗接種計劃，預計歐洲將實現強勁增長。光是英國在2024年就將擁有1,080萬隻寵物貓，這將推動疫苗需求。

亞太地區

亞太地區預計將呈現最高的複合年增長率，這主要得益於貓咪飼養率的上升和人們對貓科疾病認識的提高。預計到2024年，澳洲將擁有490萬隻寵物貓，這將顯著促進該地區的成長。

拉丁美洲、中東和非洲

由於政府主導的流浪貓疫苗接種計劃的擴大以及人們對人畜共患病風險認識的提高，預計這些地區將保持穩定增長。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 市場機遇
  • 市場趨勢

第四章：主要發現

  • 主要國家和地區貓科疾病概覽（2024 年）
  • 主要國家及地區監理現況（2024 年）
  • 貓科疾病疫苗接種概覽
  • 主要公司新技術應用
  • 主要產業趨勢（併購、合作等）

第五章：全球貓疫苗市場分析、洞察與預測（2019-2032）

  • 市場分析、洞察與預測 - 依技術分類
    • 滅活​​疫苗
    • 減毒活疫苗
    • 重組疫苗
    • 其他
  • 市場分析、洞察與預測 - 依疾病類型分類
    • 貓咪病毒性鼻氣管炎
    • 狂犬病
    • 貓白血病病毒
    • 其他
  • 市場分析、洞察與預測 - 依給藥途徑分類
    • 腸外給藥
    • 鼻腔給藥
  • 市場分析、洞察與預測 - 依銷售管道分類
    • 獸醫院
    • 動物診所
    • 藥局藥局
    • 其他
  • 市場分析、洞察與預測 - 依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美貓疫苗市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲貓疫苗市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 德國
    • 美國王國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 歐洲其他地區

第八章 亞太地區貓疫苗市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲貓疫苗市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

章節10：中東和非洲貓科動物疫苗市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 海灣合作委員會 (GCC)
    • 南非
    • 中東和非洲其他地區

第11章 競爭分析

  • 全球市佔率分析（2024）
  • 公司簡介
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Merck &Co., Inc.
  • Zoetis Services LLC
  • Ceva
  • Bioveta, a.s.
Product Code: FBI113898

Growth Factors of feline vaccines Market

The global feline vaccines market continues to expand steadily as pet ownership rises and veterinary healthcare becomes more advanced. According to the latest industry analysis, the feline vaccines market size reached USD 1.58 billion in 2024, driven by strong awareness of feline health, growing prevalence of infectious diseases, and the increased role of veterinary clinics and hospitals in preventive healthcare. The market is projected to grow further to USD 1.67 billion in 2025, influenced by expanding pet adoption and growing initiatives to prevent zoonotic diseases. By 2032, the market is expected to reach USD 2.65 billion, due to advancements in vaccine technology and increasing investment by veterinary pharmaceutical companies.

Market Drivers: Rising Cat Ownership and Growing Disease Prevalence

The primary driver supporting market growth is the significant rise in cat ownership worldwide. With households increasingly adopting cats as companion animals, the need for preventive vaccination continues to escalate. In the U.S., for example, around 49 million households owned a cat in 2023-2024, according to the American Pet Products Association. This high ownership level directly fuels the demand for core vaccines such as rabies, FeLV, FVRCP, and others.

Additionally, the prevalence of infectious diseases further strengthens market expansion. A study conducted in southern Italy showed that 73.5% of 328 domestic cats tested positive for feline panleukopenia virus, highlighting the global need for timely vaccination. With such increasing disease incidence, pet owners are more focused on safeguarding their animals through reliable vaccination programs.

Market Restraints: Limited Access in Developing Regions

Despite growth in developed markets, limited access to veterinary care in emerging regions remains a significant restraint. Countries with fewer veterinary professionals and limited vaccination infrastructure face challenges in adopting routine immunization for felines. For instance, Kenya has only 410 veterinarians, making widespread vaccination programs difficult to implement. This ultimately restricts growth potential in low-income regions.

Market Opportunities: Government Initiatives for Feline Immunization

Governments and municipal bodies across countries are increasingly adopting programs to vaccinate domestic and stray cats, creating strong market opportunities. In India, the Nashik Municipal Corporation launched a program in July 2025 to vaccinate stray cats against rabies, reflecting a broader trend of public-health-driven vaccination campaigns. Such initiatives contribute significantly to rising vaccine uptake across regions and are expected to support market value growth toward USD 2.65 billion by 2032.

Market Challenges: Vaccine Hesitancy Among Pet Owners

Vaccine hesitancy, largely driven by concerns about vaccine safety and side effects, continues to challenge market expansion. The American Veterinary Medical Association (AVMA) reported in 2024 that many pet owners remain hesitant about immunization, which creates gaps in vaccine coverage and slows overall market adoption.

Market Trends: Advancements in Vaccine Platforms

A major trend shaping the industry is the rapid development of innovative vaccine platforms such as recombinant and next-generation vaccines. Merck's expansion of the NOBIVAC NXT platform, including NOBIVAC NXT FeLV launched in 2024, highlights growing advancements focused on broader protection, longer immunity, and improved safety profiles. This continuous innovation is expected to drive strong demand between 2025 and 2032.

Regional Insights

North America - Leading Regional Market (USD 0.67 Billion in 2024)

North America accounted for the largest market share of 42.40% in 2024, with a market value of USD 0.67 billion. Strong veterinary healthcare infrastructure, high disposable income, and a large pet population underpin regional leadership. The U.S. remains the dominant country, supported by advanced veterinary guidelines and a robust vaccine distribution network.

Europe

Europe is set for strong growth due to increasing pet population, rising cases of feline diseases, and government-supported vaccination programs. The U.K. alone had 10.8 million pet cats in 2024, boosting vaccine demand.

Asia Pacific

Asia Pacific is projected to exhibit the fastest CAGR, driven by rising cat ownership and growing awareness of feline diseases. Australia reported 4.9 million pet cats in 2024, contributing heavily to regional growth.

Latin America & Middle East & Africa

These regions will experience steady growth due to increasing government-run stray cat vaccination programs and rising awareness of zoonotic risks.

Competitive Landscape

The market is semi-consolidated, with top players including Zoetis Services LLC, Merck & Co., Inc., Elanco, Virbac, Boehringer Ingelheim, Ceva, and Bioveta. These companies invest heavily in R&D, new vaccine platforms, and expanded manufacturing capabilities to sustain market leadership.

Segmentation By Technology

  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others

By Disease Type

  • Feline Viral Rhinotracheitis
  • Rabies
  • Feline Leukemia Virus
  • Others

By Route of Administration

  • Parenteral
  • Intranasal

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

By Region

  • North America (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • U.S.
    • Canada
  • Europe (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Overview of Feline Diseases by Key Countries, By Key Countries/ Region, 2024
  • 4.2. Regulatory Scenario by Key Countries/ Region, 2024
  • 4.3. Overview of Vaccination for Feline Diseases
  • 4.4. New Technology Launches, By Key Players
  • 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)

5. Global Feline Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Technology
    • 5.1.1. Inactivated
    • 5.1.2. Live Attenuated
    • 5.1.3. Recombinant
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Disease Type
    • 5.2.1. Feline Viral Rhinotracheitis
    • 5.2.2. Rabies
    • 5.2.3. Feline Leukemia Virus
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Parenteral
    • 5.3.2. Intranasal
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Veterinary Hospitals
    • 5.4.2. Veterinary Clinics
    • 5.4.3. Pharmacies & Drug Stores
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Feline Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Technology
    • 6.1.1. Inactivated
    • 6.1.2. Live Attenuated
    • 6.1.3. Recombinant
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Disease Type
    • 6.2.1. Feline Viral Rhinotracheitis
    • 6.2.2. Rabies
    • 6.2.3. Feline Leukemia Virus
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Parenteral
    • 6.3.2. Intranasal
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Veterinary Hospitals
    • 6.4.2. Veterinary Clinics
    • 6.4.3. Pharmacies & Drug Stores
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Feline Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Technology
    • 7.1.1. Inactivated
    • 7.1.2. Live Attenuated
    • 7.1.3. Recombinant
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Disease Type
    • 7.2.1. Feline Viral Rhinotracheitis
    • 7.2.2. Rabies
    • 7.2.3. Feline Leukemia Virus
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Parenteral
    • 7.3.2. Intranasal
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Veterinary Hospitals
    • 7.4.2. Veterinary Clinics
    • 7.4.3. Pharmacies & Drug Stores
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.5.1. Germany
    • 7.5.2. U.K.
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Feline Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Technology
    • 8.1.1. Inactivated
    • 8.1.2. Live Attenuated
    • 8.1.3. Recombinant
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Disease Type
    • 8.2.1. Feline Viral Rhinotracheitis
    • 8.2.2. Rabies
    • 8.2.3. Feline Leukemia Virus
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Parenteral
    • 8.3.2. Intranasal
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Veterinary Hospitals
    • 8.4.2. Veterinary Clinics
    • 8.4.3. Pharmacies & Drug Stores
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Feline Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Technology
    • 9.1.1. Inactivated
    • 9.1.2. Live Attenuated
    • 9.1.3. Recombinant
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Disease Type
    • 9.2.1. Feline Viral Rhinotracheitis
    • 9.2.2. Rabies
    • 9.2.3. Feline Leukemia Virus
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Parenteral
    • 9.3.2. Intranasal
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Veterinary Hospitals
    • 9.4.2. Veterinary Clinics
    • 9.4.3. Pharmacies & Drug Stores
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Feline Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Technology
    • 10.1.1. Inactivated
    • 10.1.2. Live Attenuated
    • 10.1.3. Recombinant
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Disease Type
    • 10.2.1. Feline Viral Rhinotracheitis
    • 10.2.2. Rabies
    • 10.2.3. Feline Leukemia Virus
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Parenteral
    • 10.3.2. Intranasal
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Veterinary Hospitals
    • 10.4.2. Veterinary Clinics
    • 10.4.3. Pharmacies & Drug Stores
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles (Overview, Technology, SWOT analysis, Recent developments, strategies, financials (based on availability)
    • 11.2.1. Elanco
    • 11.2.2. Boehringer Ingelheim International GmbH
    • 11.2.3. Virbac
    • 11.2.4. Merck & Co., Inc.
    • 11.2.5. Zoetis Services LLC
    • 11.2.6. Ceva
    • 11.2.7. Bioveta, a.s.

List of Tables

  • Table 1: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 2: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 3: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 4: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 5: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 6: North America Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 7: North America Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 8: North America Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 9: North America Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 10: North America Feline Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 11: Europe Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 12: Europe Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 13: Europe Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 14: Europe Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 15: Europe Feline Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 16: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 17: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 18: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 19: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 20: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 21: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 22: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 23: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 24: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 25: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 26: Middle East & Africa Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 27: Middle East & Africa Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 28: Middle East & Africa Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 29: Middle East & Africa Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

List of Figures

  • Figure 1: Global Feline Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Feline Vaccines Market Value Share (%), by Technology, 2024 & 2032
  • Figure 3: Global Feline Vaccines Market Value Share (%), by Disease Type, 2024 & 2032
  • Figure 4: Global Feline Vaccines Market Value Share (%), by Route of Administration, 2024 & 2032
  • Figure 5: Global Feline Vaccines Market Value Share (%), by Distribution Channel, 2024 & 2032
  • Figure 6: Global Feline Vaccines Market Value Share (%), by Region, 2024 & 2032
  • Figure 7: North America Feline Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 8: North America Feline Vaccines Market Value Share (%), by Technology, 2024
  • Figure 9: North America Feline Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 10: North America Feline Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 11: North America Feline Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 12: North America Feline Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 13: North America Feline Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 14: North America Feline Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 15: North America Feline Vaccines Market Value (USD billion), By Country, 2024 & 2032
  • Figure 16: North America Feline Vaccines Market Value Share (%), By Country, 2024
  • Figure 17: Europe Feline Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 18: Europe Feline Vaccines Market Value Share (%), by Technology, 2024
  • Figure 19: Europe Feline Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 20: Europe Feline Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 21: Europe Feline Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 22: Europe Feline Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 23: Europe Feline Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 24: Europe Feline Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 25: Europe Feline Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 26: Europe Feline Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 27: Asia Pacific Feline Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 28: Asia Pacific Feline Vaccines Market Value Share (%), by Technology, 2024
  • Figure 29: Asia Pacific Feline Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 30: Asia Pacific Feline Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 31: Asia Pacific Feline Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 32: Asia Pacific Feline Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 33: Asia Pacific Feline Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 34: Asia Pacific Feline Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 35: Asia Pacific Feline Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 36: Asia Pacific Feline Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 37: Latin America Feline Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 38: Latin America Feline Vaccines Market Value Share (%), by Technology, 2024
  • Figure 39: Latin America Feline Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 40: Latin America Feline Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 41: Latin America Feline Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 42: Latin America Feline Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 43: Latin America Feline Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 44: Latin America Feline Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 45: Latin America Feline Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 46: Latin America Feline Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 47: Middle East & Africa Feline Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 48: Middle East & Africa Feline Vaccines Market Value Share (%), by Technology, 2024
  • Figure 49: Middle East & Africa Feline Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 50: Middle East & Africa Feline Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 51: Middle East & Africa Feline Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 52: Middle East & Africa Feline Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 53: Middle East & Africa Feline Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 54: Middle East & Africa Feline Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 55: Middle East & Africa Feline Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 56: Middle East & Africa Feline Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 57: Global Feline Vaccines Market Share (%), By Company, 2024